[{"Assets_0_Q2_USD":605745000.0,"CommonStockSharesOutstanding_0_Q2_shares":40318129.0,"EarningsPerShareBasic_1_Q2_USD":-0.49,"EarningsPerShareBasic_2_Q2_USD":-1.01,"NetIncomeLoss_1_Q2_USD":-19743000.0,"NetIncomeLoss_2_Q2_USD":-39609000.0,"StockholdersEquity_0_Q2_USD":261048000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":40160000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":39079000.0,"Ticker":"PCRX","CIK":"1396814","name":"PACIRA PHARMACEUTICALS, INC.","OfficialName":"Pacira BioSciences Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3316489486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]